Targeting HER2 Alterations in NSCLC with Dr. Barbara Melosky

Summiting Perioperative Gastric Cancer - With Dr. Howie Lim

In this episode, Dr. Howard Lim takes us through the peri-operative management of Gastric/GEJ Adenocarcinoma. This is particularly timely given Ontario now has funded access to the Matterhorn regimen, with the hopes of other provinces to follow.

Abema and Ribo - Adjuvant High Risk EBC with Dr. Aalok Kumar

In this episode, Dr. Aalok Kumar takes us through the practical aspects of choosing between the available adjuvant intensification options in "High Risk" HR+, HER2 - Early Breast Cancer. This is timely given there is public funding for Abemaciclib and PSP support for Ribociclib.

Targeted therapy in Cholangiocarcinoma - Part 2 - Ivosidenib

In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib (PART 1) to target FGFR2 fusions and Ivosidenib (PART 2) for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate these into practice.

Targeted therapy in Cholangiocarcinoma - Part 1 - Pemigatinib

In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib to target FGFR2 fusions and Ivosidenib for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate these into practice.

You Are What You Eat - Diet and Cancer with Dr. Urvi Shah

In this episode, Dr. Urvi Shah takes us through how to optimize diet in cancer treatment and prevention.